An Infectious cDNA Clone of SARS-CoV-2 is a research paper published in Cell Host & Microbe (2020). On theSindex it has a DataRank of 0.995. It has been cited 761 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.995
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5UC7AI094660
National Institutes of Health
Grant: AI114657
National Institutes of Health
Grant: AI146081
National Institutes of Health
Grant: R00AG049092
National Institutes of Health
Grant: R24AI120942
National Institutes of Health
Grant: U19AI100625
University of Texas System
Grant: AI127744
University of Texas System
Grant: AI134907
University of Texas System
Grant: AI136126
University of Texas System
Grant: AI142759
University of Texas System
Grant: AI145617
University of Texas System
Grant: UL1TR001439
NIAID NIH HHS
Grant: R41 AI136126
NIAID NIH HHS
Grant: R01 AI114657
NIAID NIH HHS
Grant: UC7 AI094660
NIAID NIH HHS
Grant: R01 AI127744
NIAID NIH HHS
Grant: R43 AI145617
NIAID NIH HHS
Grant: U19 AI142759
NIAID NIH HHS
Grant: R01 AI146081
NIAID NIH HHS
Grant: R01 AI134907
NCATS NIH HHS
Grant: TL1 TR001440
National Institutes of Health
Grant: 3U19AI100625-08S1
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
National Institutes of Health
Grant: 5U19AI142759-04
Antiviral Drug Discovery and Development Center (AD3C)
National Institutes of Health
Grant: 5TL1TR001440-08
NRSA Training Core
National Institutes of Health
Grant: 1R43AI145617-01A1
Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats
National Institutes of Health
Grant: 5R41AI136126-02
Discovery of Zika virus therapeutics using a replicon assay
National Institutes of Health
Grant: 5R01AI127744-05
Revolutionary Eilat-based Chikungunya Vaccine Vector
National Institutes of Health
Grant: 5UC7AI094660-03
National Biocontainment Laboratories (NBLs) Operations Support
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
National Institutes of Health
Grant: 5R24AI120942-05
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
National Institutes of Health
Grant: 4R00AG049092-03
Systems Based Analysis of Host Factors that Contribute to Aging Pathogenesis
National Institutes of Health
Grant: 3R01AI134907-03S2
A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery
Centers for Disease Control and Prevention
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
University of Texas Medical Branch
National Institute of Allergy and Infectious Diseases
Amon G. Carter Foundation
John S. Dunn Foundation
Gillson Longenbaugh Foundation
Summerfield G. Roberts Foundation
National Institute on Aging
FWCI
15.57
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
Additional file 1 of Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2